JP2023082054A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023082054A5 JP2023082054A5 JP2023047827A JP2023047827A JP2023082054A5 JP 2023082054 A5 JP2023082054 A5 JP 2023082054A5 JP 2023047827 A JP2023047827 A JP 2023047827A JP 2023047827 A JP2023047827 A JP 2023047827A JP 2023082054 A5 JP2023082054 A5 JP 2023082054A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- amino acid
- acid sequence
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762460118P | 2017-02-17 | 2017-02-17 | |
| US62/460,118 | 2017-02-17 | ||
| PCT/US2018/018557 WO2018152451A1 (en) | 2017-02-17 | 2018-02-17 | Targeted ligand-payload based drug delivery for cell therapy |
| JP2019544016A JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544016A Division JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023082054A JP2023082054A (ja) | 2023-06-13 |
| JP2023082054A5 true JP2023082054A5 (https=) | 2023-07-19 |
Family
ID=63170493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544016A Active JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
| JP2023047827A Pending JP2023082054A (ja) | 2017-02-17 | 2023-03-24 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544016A Active JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US12343403B2 (https=) |
| EP (2) | EP3583218B1 (https=) |
| JP (2) | JP7288402B2 (https=) |
| KR (1) | KR102595249B1 (https=) |
| CN (2) | CN110662839A (https=) |
| AU (1) | AU2018221171B2 (https=) |
| CA (1) | CA3053534A1 (https=) |
| ES (1) | ES3024357T3 (https=) |
| WO (1) | WO2018152451A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2934532B1 (en) | 2012-12-20 | 2019-10-23 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| JP2019508036A (ja) | 2016-02-16 | 2019-03-28 | ダナ−ファーバー キャンサー インスティテュート，インコーポレイテッド | 免疫療法組成物及び方法 |
| JP7282521B2 (ja) | 2016-04-08 | 2023-05-29 | パーデュー・リサーチ・ファウンデイション | Ｃａｒ ｔ細胞療法のための方法および組成物 |
| CN110612119B (zh) | 2017-02-07 | 2024-10-29 | 西雅图儿童医院（Dba西雅图儿童研究所） | 磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂 |
| CN110662839A (zh) * | 2017-02-17 | 2020-01-07 | 珀杜研究基金会 | 用于细胞疗法的基于靶向性配体-有效负载的药物递送 |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| JP7549303B2 (ja) * | 2018-01-22 | 2024-09-11 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞の使用方法 |
| SG11202007426XA (en) | 2018-02-06 | 2020-09-29 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors |
| CN112105382A (zh) | 2018-02-23 | 2020-12-18 | 恩多塞特公司 | 用于car t细胞疗法的顺序方法 |
| CN112262214A (zh) | 2018-04-12 | 2021-01-22 | 优莫佳生物制药股份有限公司 | 病毒载体及包装细胞系 |
| AU2019291882A1 (en) | 2018-06-28 | 2020-11-26 | Dana-Farber Cancer Institute, Inc. | Targeting of multiple antigens with multiplex CAR T cells in solid and liquid malignancies |
| KR20210042125A (ko) * | 2018-08-07 | 2021-04-16 | 퍼듀 리서치 파운데이션 | Car t 세포의 회생 |
| US20220251108A1 (en) | 2019-01-23 | 2022-08-11 | The Johns Hopkins University | Non-immunosuppressive fk506 analogs and use thereof |
| US20230038502A1 (en) | 2019-06-11 | 2023-02-09 | Shire Human Genetic Therapies, Inc. | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| CN114555788A (zh) * | 2019-09-06 | 2022-05-27 | 阿维塔斯有限公司 | 免疫细胞工程化用于体外细胞治疗 |
| EP4048800A1 (en) | 2019-10-23 | 2022-08-31 | Shire Human Genetic Therapies, Inc. | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
| AU2021217003A1 (en) | 2020-02-04 | 2022-09-15 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Anti-dinitrophenol chimeric antigen receptors |
| WO2022044024A1 (en) * | 2020-08-31 | 2022-03-03 | Ramot At Tel-Aviv University Ltd. | Small molecule modulators of gsk-3 activity |
| US20220186252A1 (en) | 2020-12-16 | 2022-06-16 | Takeda Pharmaceutical Company Limited | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| CA3203105A1 (en) * | 2020-12-22 | 2022-06-30 | Michael H. Cardone | Methods and compositions related to bcl2 and bim heterodimer antibodies |
| CN113462649B (zh) * | 2021-05-27 | 2022-08-23 | 浙江大学 | Mek抑制剂在减少car-t细胞耗竭和终末分化中的应用 |
| US20250084175A1 (en) * | 2021-07-21 | 2025-03-13 | Immunitybio, Inc. | GENERATION OF CHIMERIC ANTIGEN RECEPTOR mRNA MOLECULES FOR EXPRESSION IN PRIMARY NK CELLS |
| CN116041545A (zh) * | 2022-12-12 | 2023-05-02 | 南方医科大学 | 一种靶向荧光素或生物素的通用型car及其应用 |
| WO2024206913A2 (en) * | 2023-03-31 | 2024-10-03 | Northwestern University | Compositions for antigen-specific immune cell activation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9523469D0 (en) * | 1995-11-16 | 1996-01-17 | Sandoz Ltd | Organic compounds |
| US6093382A (en) | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| SI2371854T1 (sl) | 2001-03-09 | 2014-09-30 | Board Of Regents, The University Of Texas System Office Of The General Counsel | Induciranje imunosti tumorja z variantami beljakovine, ki se veĺ˝e na folat |
| WO2005103250A1 (ja) * | 2004-04-26 | 2005-11-03 | Takami Matsuyama | 葉酸リセプターベータ（FR-β）に対する単クローン抗体を含有する治療薬 |
| CN102458442B (zh) | 2009-04-08 | 2016-06-29 | 加利福尼亚大学董事会 | 具有受控血清药代动力学的人蛋白支架 |
| US20120258905A1 (en) * | 2009-12-23 | 2012-10-11 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| US20190054117A1 (en) | 2014-12-19 | 2019-02-21 | Novartis Ag | Dimerization switches and uses thereof |
| US10683506B2 (en) * | 2015-04-10 | 2020-06-16 | The Methodist Hospital System | CD117 ligand-drug conjugates for targeted cancer therapy |
| CN108990413A (zh) * | 2015-08-12 | 2018-12-11 | 麻省理工学院 | 纳米颗粒的细胞表面偶联 |
| AU2017207936A1 (en) * | 2016-01-15 | 2018-07-26 | Etubics Corporation | Methods and compositions for T-cell immunotherapy |
| CN110267982B (zh) * | 2016-10-19 | 2024-02-23 | 斯克利普斯研究所 | 具有人源化靶向部分和/或经过优化的嵌合抗原受体相互作用结构域的嵌合抗原受体效应细胞开关以及其用途 |
| AU2017355218B2 (en) * | 2016-11-02 | 2024-02-22 | Universität Basel | Immunologically discernible cell surface variants for use in cell therapy |
| CN110662839A (zh) | 2017-02-17 | 2020-01-07 | 珀杜研究基金会 | 用于细胞疗法的基于靶向性配体-有效负载的药物递送 |
-
2018
- 2018-02-17 CN CN201880024308.6A patent/CN110662839A/zh active Pending
- 2018-02-17 EP EP18754879.7A patent/EP3583218B1/en active Active
- 2018-02-17 WO PCT/US2018/018557 patent/WO2018152451A1/en not_active Ceased
- 2018-02-17 ES ES18754879T patent/ES3024357T3/es active Active
- 2018-02-17 CN CN202410423409.8A patent/CN118634339B/zh active Active
- 2018-02-17 AU AU2018221171A patent/AU2018221171B2/en active Active
- 2018-02-17 CA CA3053534A patent/CA3053534A1/en active Pending
- 2018-02-17 US US16/486,632 patent/US12343403B2/en active Active
- 2018-02-17 JP JP2019544016A patent/JP7288402B2/ja active Active
- 2018-02-17 EP EP25163099.2A patent/EP4600267A3/en active Pending
- 2018-02-17 KR KR1020197026818A patent/KR102595249B1/ko active Active
-
2023
- 2023-03-24 JP JP2023047827A patent/JP2023082054A/ja active Pending
-
2025
- 2025-04-30 US US19/194,112 patent/US20250262313A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023082054A5 (https=) | ||
| JP2018138049A5 (https=) | ||
| JP2019500414A5 (https=) | ||
| JP2010510315A5 (https=) | ||
| JP2019122392A5 (https=) | ||
| JP2017018125A5 (https=) | ||
| JP2005120106A5 (https=) | ||
| HRP20090245T1 (en) | Pyy agonists and uses thereof | |
| ATE401390T1 (de) | Zytokin (zcytor17-ligand) | |
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| JP2019214579A5 (https=) | ||
| JP2007508034A5 (https=) | ||
| MX2021004714A (es) | Proteina cas9 modificada, y uso de la misma. | |
| JP2019512693A5 (https=) | ||
| JP2022119899A5 (https=) | ||
| JP2018529626A5 (https=) | ||
| DK200601181A (da) | Fiskevaccine | |
| JPWO2020027010A5 (https=) | ||
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2020127419A5 (https=) | ||
| JP2008517998A5 (https=) | ||
| JP2019038772A5 (https=) | ||
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| JP2018529625A5 (https=) | ||
| JP2009511036A5 (https=) |